SMSPHARMA

SMS Pharmaceuticals Ltd.

NSE: SMSPHARMA

BSE: 532815

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

399.15+1.2 (+0.30%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

62.3 / 100

Value Score

25.1 / 100

Price Momentum Score

75.7 / 100

QVM Score

55.3 / 100

Key Metrics

Market Cap

3738.12

P/E (TTM)

36.65

P/B

4.76

P/S (TTM)

4.16

EV/EBITDA

23.67

CAPE (5Y)

62.93

ROE (TTM)

14.31

ROCE (TTM)

12.50

ROA (TTM)

8.11

Avg 3Y ROE

12.02

Earnings 3Y CAGR

Sales 3Y CAGR

14.83

Sales 5Y CAGR

7.92

Debt/Equity

0.46

Consensus TP

464.00

Strong Buy %

Promoter Holding

68.07

Pledged %

17.99

Stock Analysis

Fundamental analysis overview of SMS Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 75.7 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

75.7 / 100

Moderate ROE but improving trend

The company reported moderate ROE of 14.31% for 12-month ended 30 Jun 2026 but ROE improved by 254 bps from 1 year ago

What is ROE (FY)?

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 36.64% for 12-month ended 30 Jun 2026 and the growth was 29.44 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.46 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.03 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 36.65 indicates that the stock is expensive on a standalone basis and is at a 15.32% premium to industry median P/E

What is P/E Ratio?

Median: 31.78

Value 36.65

-0.96721.13

Low dividend yield

The company has a low dividend yield of 0.1%

What is Dividend yield?

Neutral

Moderate and stable operating margin

The company reported moderate operating margin of 14.81% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 140 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 10.25% for 12-month ended 30 Jun 2026 and the growth was 0.34 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 10.25

-99.6111701.8

Company's earnings are of moderate quality

Earnings quality score of 41.2 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

41.2 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for SMS Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

SMS Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of SMS Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	68.69	67.29	67.29	67.29	67.29	67.29	67.29	67.29	67.29	64.17	64.17	64.17	64.29	64.32	64.32	64.32	64.67	64.67	64.67	64.67	66.26	66.26	68.07	68.07	68.07	68.07
Indian Promoter	68.69	67.29	67.29	67.29	67.29	67.29	67.29	67.29	67.29	64.17	64.17	64.17	64.29	64.32	64.32	64.32	64.67	64.67	64.67	64.67	66.26	66.26	68.07	68.07	68.07	68.07
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.51	0.53	0.30	0.56	0.56	0.91	0.94	0.65	0.61	0.63	0.59	0.59	0.59	0.67	0.60	0.59	2.15	2.30	3.07	2.86	2.51	3.06	3.16	3.25	3.32	3.48
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	1.98	2.13	2.55	2.55	2.43	3.03	2.88	3.21	2.96	2.81
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.51	0.53	0.30	0.56	0.56	0.91	0.94	0.65	0.61	0.63	0.59	0.59	0.59	0.67	0.60	0.59	0.17	0.18	0.52	0.31	0.08	0.03	0.28	0.04	0.31	0.65
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.05	0.02
Non-Institution	30.80	32.17	32.41	32.15	32.15	31.79	31.76	32.06	32.10	35.20	35.23	35.23	35.12	35.01	35.06	35.09	33.17	33.03	32.26	32.47	31.22	30.67	28.78	28.69	28.61	28.45
Bodies Corporate	2.77	2.74	2.21	2.23	2.39	2.06	2.67	2.39	2.82	2.77	2.94	2.95	2.66	2.55	2.55	2.39	1.75	1.76	1.74	1.65	1.60	1.49	1.62	1.44	1.73	1.41
Others (incl. Retail) No. of shareholders	28.03 15,581	29.43 18,885	30.20 29,044	29.92 21,535	29.76 19,779	29.73 25,490	29.09 24,494	29.67 24,846	29.28 27,412	32.43 26,543	32.29 26,390	32.28 26,427	32.46 25,441	32.46 24,546	32.51 25,141	32.70 25,233	31.42 30,023	31.27 31,658	30.52 33,015	30.82 34,855	29.62 35,213	29.18 33,540	27.16 34,009	27.25 34,242	26.88 32,245	27.04 31,321

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

SMS Pharmaceuticals Ltd. is not part of any tracked index.

Prominent Investor Holdings

Madhusudan Kela and Associates

Jun 2021

1.10%

₹ 37 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in SMS Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
P. Deepthi Sri Employees Immediate Relative	June-2026	Market Sale (Disposal) 2nd Jun 2026	0.01 %	₹ 316.00	5.00 k	₹ 15.80 lac
P. Manideep Employees Immediate Relative	March-2026	Market Sale (Disposal) 16th Mar 2026	0.03 %	₹ 385.00	1.00 k	₹ 3.85 lac
P. Manideep Employees Immediate Relative	March-2026	Market Sale (Disposal) 16th Mar 2026	0.03 %	₹ 417.33	1.50 k	₹ 6.26 lac
P. Srinivasa Rao Employee	February-2026	Market Sale (Disposal) 28th Feb 2026	0.00 %	₹ 389.89	2.00 k	₹ 7.80 lac
G. Suresh Kumar Director	February-2026	Market Sale (Disposal) 28th Feb 2026	0.02 %	₹ 395.63	5.00 k	₹ 19.78 lac
P. Srinivasa Rao Employee	February-2026	Market Sale (Disposal) 28th Feb 2026	0.00 %	₹ 395.16	3.01 k	₹ 11.88 lac
G. Suresh Kumar Director	February-2026	Market Sale (Disposal) 24th Feb 2026	0.02 %	₹ 372.90	1.00 k	₹ 3.73 lac
G. Suresh Kumar Director	February-2026	Market Sale (Disposal) 19th Feb 2026	0.02 %	₹ 369.80	1.12 k	₹ 4.14 lac
G. Suresh Kumar Director	November-2025	Market Sale (Disposal) 28th Nov 2025	0.02 %	₹ 298.50	3.00 k	₹ 8.95 lac
Vamsi Krishna Potluri Promoter Group	September-2025	Conversion of security (Acquisition) 11th Sep 2025	15.03 %	₹ 95.25	25.00 lac	₹ 23.81 cr

Corporate Actions

History of SMS Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.40/share
Record date: 22nd Sep 2026Ex-date: 22nd Sep 2026
Announced on: 22nd May 2026
Dividend₹ 0.40/share
Record date: 22nd Sep 2025Ex-date: 22nd Sep 2025
Announced on: 30th May 2025
Dividend₹ 0.40/share
Record date: 23rd Sep 2024Ex-date: 23rd Sep 2024
Announced on: 29th May 2024
Dividend₹ 0.30/share
Record date: 22nd Sep 2023Ex-date: 22nd Sep 2023
Announced on: 24th May 2023
Dividend₹ 0.30/share
Record date: 23rd Sep 2022Ex-date: 22nd Sep 2022
Announced on: 30th May 2022

Company Profile

Overview of SMS Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, an...

Key personnel

Sri. Lakshmi Narayana Tammineedi

Chief Financial Officer

Mr. Thirumalesh Tumma

Chief Compliance Officer, Company Secretary

Shri. Ramesh Babu PotluriD

Executive Chairman of the Board, Managing Director

Mr. Vamsi Krishna PotluriD

Whole Time Director

Mr. Trilok PotluriD

Non-Executive Non-Independent Director

Dr. Sunkara Venkata Sa PrasadD

Non-Executive Non Independent Director

Mrs. Shanti Sree BolleniD

Non-Executive Independent Director

Dr. Suresh Kumar GangavarapuD

Non-Executive Independent Director

View all

Incorporated on

14 Dec 1987

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,617

IPO date

25 Feb 2007

Free Float

2,19,38,283

Website

https://smspharma.com/

Phone no.

+914025259999

Address

Plot No.72, H. No.8-2-334/3 & 4 Road No.5, Opp. SBI Executive Enclave, Banjara Hills, HYDERABAD, 500034, India

Frequently Asked Questions

What is the current share price of SMS Pharmaceuticals Ltd.?

The current share price of SMS Pharmaceuticals Ltd. is ₹ 399.15 as of 8 Sep 2026.

What is the market capitalisation of SMS Pharmaceuticals Ltd.?

The market capitalisation of SMS Pharmaceuticals Ltd. stands at ₹ 3,738.12 Cr.

What is the PE ratio of SMS Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of SMS Pharmaceuticals Ltd. is 36.65 as of the latest trailing twelve months data.

What is the ROE and ROCE of SMS Pharmaceuticals Ltd.?

SMS Pharmaceuticals Ltd. has a Return on Equity (ROE) of 14.31% and a Return on Capital Employed (ROCE) of 12.50% as per the latest financial reports.

What is the 52-week high and low of SMS Pharmaceuticals Ltd.?

The 52-week high of SMS Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of SMS Pharmaceuticals Ltd.?

The dividend yield of SMS Pharmaceuticals Ltd. is 0.10% based on the current market price.

What is the FII and DII holding in SMS Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.65%, Domestic Institutional Investors (DII) hold 2.81% and retail/public investors hold 27.04% of SMS Pharmaceuticals Ltd. shares.

What sector does SMS Pharmaceuticals Ltd. belong to?

SMS Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of SMS Pharmaceuticals Ltd.?

The beta of SMS Pharmaceuticals Ltd. is 1.25, indicating its price volatility relative to the broader market. Over the past 1 year, SMS Pharmaceuticals Ltd. has delivered an absolute return of 70.18%.

What is the RSI of SMS Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of SMS Pharmaceuticals Ltd. is 66.55, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

SMS Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

SMS Pharmaceuticals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Holdings and Presence

Company Profile